Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Merus N.v. buy BiotechBee

Merus N.v.
Start price
€23.20
24.06.23 / 70%
Target price
€40.00
30.04.26
Performance (%)
76.72%
End price
€41.00
14.12.24
Summary
This prediction ended on 14.12.24 with a price of €41.00. With a performance of 76.72% the BUY prediction by BiotechBee was a big success. BiotechBee has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Merus N.v. - - -
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

According to BiotechBee what are the pros and cons of Merus N.v. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Merus N.v. diskutieren
Prediction Buy
Perf. (%) 76.72%
Target price 40.000
Change
Ends at 30.04.26

Buy mit Kursziel 40,0

BiotechBee 
0
Report Share
24.06.23
In the thread Trading Merus N.v.
Prediction Buy
Perf. (%) 76.72%
Target price 40.000
Change
Ends at 30.04.26

Buy beendet

BiotechBee 
0
Report Share
14.12.24